Exploring Dengue Infection in a Vaccinated Individual: Preliminary Molecular Diagnosis and Sequencing Insights

Viruses. 2024 Oct 12;16(10):1603. doi: 10.3390/v16101603.

Abstract

This study examines a case involving a 7-year-old child who developed dengue symptoms following Qdenga vaccination. Despite initial negative diagnostic results, molecular analysis confirmed an infection with DENV4. Next-generation sequencing detected viral RNA from both DENV2 and DENV4 serotypes, which were identified as vaccine-derived strains using specific primers. Phylogenetic analysis further confirmed that these sequences belonged to the Qdenga vaccine rather than circulating wild-type viruses. This case underscores the critical need for precise diagnostic interpretation in vaccinated individuals to avoid misdiagnosis and to strengthen public health surveillance. A comprehensive understanding of vaccine-induced viremia is essential for refining dengue surveillance, improving diagnostic accuracy, and informing public health strategies in endemic regions.

Keywords: DENV monitoring; genomic surveillance; next-generation sequencing; vaccine breakthrough.

Publication types

  • Case Reports

MeSH terms

  • Child
  • Dengue Vaccines* / administration & dosage
  • Dengue Vaccines* / genetics
  • Dengue Vaccines* / immunology
  • Dengue Virus* / classification
  • Dengue Virus* / genetics
  • Dengue Virus* / immunology
  • Dengue* / diagnosis
  • Dengue* / virology
  • High-Throughput Nucleotide Sequencing*
  • Humans
  • Male
  • Phylogeny*
  • RNA, Viral* / genetics
  • Serogroup
  • Vaccination

Substances

  • Dengue Vaccines
  • RNA, Viral